Rapid analysis of factor V Leiden mutation by membrane mediated restriction digestion and ultra-thin layer gel electrophoresis

被引:2
作者
Guttman, A
Ronai, Z
Khandurina, J
Lengyel, T
Sasvari-Szekely, M
机构
[1] Diversa Co, San Diego, CA 92121 USA
[2] Genet Biosyst, San Diego, CA 92130 USA
[3] Torrey Mesa Res Inst, San Diego, CA 92121 USA
关键词
ultra-thin layer gel electrophoresis; membrane mediated restriction digestion; Leiden mutation;
D O I
10.1365/s10337-004-0272-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Mutation of blood coagulation factor V at the protein C cleavage site (Leiden mutation) results in activated protein C resistancy and concomitant blood clotting. Individuals that carry this mutation have significantly increased risk of thrombic episodes. Using polymerase chain reaction/ restriction fragment length polymorphism (PCR/RFLP) analysis, single nucleotide polymorphisms (SNP) such as the factor V Leiden mutation can be readily detected. In this paper, we discuss the applicability of membrane mediated restriction endonuclease digestion in sub-microliter volumes, in conjunction with ultra-thin layer agarose gel electrophoresis for rapid genotyping of factor V Leiden. The amplified and restriction enzyme digested DNA fragments were fluorescently labeled with ethidium bromide during the electrophoresis separation process. Combining membrane mediated restriction digestion with ultra-thin layer agarose gel electrophoresis separation and sensitive on-line laser-induced fluorescence detection enabled completion both the digestion and electrophoresis analysis procedures in less than 15 minutes for up to 96 samples, thus, genotyping of factor V Leiden mutation with this new protocol can be accomplished in a sensitive and high throughput manner.
引用
收藏
页码:S295 / S298
页数:4
相关论文
共 26 条
[1]   Simple and reliable factor V genotyping by PNA-mediated PCR clamping [J].
Behn, M ;
Schuermann, M .
THROMBOSIS AND HAEMOSTASIS, 1998, 79 (04) :773-777
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   Membrane-mediated sample loading for automated DNA sequencing [J].
Cassel, SM ;
Guttman, A .
ELECTROPHORESIS, 1998, 19 (8-9) :1341-1346
[4]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[5]   Regulation of blood coagulation [J].
Esmon, CT .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :349-360
[6]   Screening for mutations of 21-hydroxylase gene in hungarian patients with congenital adrenal hyperplasia [J].
Ferenczi, A ;
Garami, M ;
Kiss, E ;
Pék, M ;
Sasvári-Székely, M ;
Barta, C ;
Staub, M ;
Sólyom, J ;
Fekete, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) :2369-2372
[7]   ACTIVATED PROTEIN-C RESISTANCE CAUSED BY ARG506GLN MUTATION IN FACTOR VA [J].
GREENGARD, JS ;
SUN, X ;
XU, X ;
FERNANDEZ, JA ;
GRIFFIN, JH ;
EVATT, B .
LANCET, 1994, 343 (8909) :1361-1362
[8]   DEFICIENCY OF PROTEIN-C IN CONGENITAL THROMBOTIC DISEASE [J].
GRIFFIN, JH ;
EVATT, B ;
ZIMMERMAN, TS ;
KLEISS, AJ ;
WIDEMAN, C .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1370-1373
[9]  
Guttman A, 1999, LC GC N AM, V17, P1020
[10]  
Guttman A, 2002, ELECTROPHORESIS, V23, P1524, DOI 10.1002/1522-2683(200205)23:10<1524::AID-ELPS1524>3.0.CO